"synopsis" may belong to another edition of this title.
"About this title" may belong to another edition of this title.
Shipping:
£ 9.98
From United Kingdom to U.S.A.
Book Description Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Seller Inventory # ria9780123693709_lsuk
Book Description PF. Condition: New. Seller Inventory # 6666-IUK-9780123693709
Book Description Paperback / softback. Condition: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days. Seller Inventory # C9780123693709
Book Description Condition: New. New. In shrink wrap. Looks like an interesting title! 1.41. Seller Inventory # Q-0123693705
Book Description Seller Inventory # STOCK15805072
Book Description Condition: New. This book is the first systematic, detailed treatment of the approaches to ethical issues taken by biotech and pharmaceutical companies. The application of genetic/genomic technologies raises a whole spectrum of ethical questions affecting global health tha. Seller Inventory # 897393358
Book Description Taschenbuch. Condition: Neu. Neuware - This book is the first systematic, detailed treatment of the approaches to ethical issues taken by biotech and pharmaceutical companies. The application of genetic/genomic technologies raises a whole spectrum of ethical questions affecting global health that must be addressed. Topics covered in this comprehensive survey include considerations for bioprospecting in transgenics, genomics, drug discovery, and nutrigenomics, as well as how to improve stakeholder relations, design ethical clinical trials, avoid conflicts of interest, and establish ethics advisory boards. The expert authors represent multiple disciplines including law, medicine, bioinformatics, pharmaceutics, business, and ethics. Seller Inventory # 9780123693709